Last $3.65 USD
Change Today +0.055 / 1.53%
Volume 2.0M
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 1:33 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stelios Papadopoulos Ph.D.

Co-Founder, Chairman and Member of Audit Committee, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 101 board members in 11 different organizations across 13 different industries.

See Board Relationships
66$554,855

Background*

Dr. Stelios Papadopoulos, Ph.D. served as Managing Director of Life Sciences Investment Banking division at SG Cowen Securities Corp until August 2006. In 1987, Dr. Papadopoulos served as the Vice President at the Equity Research Department at Drexel Burnham Lambert, covering the biotechnology industry. He is a private biotechnology investor. His career in biopharmaceuticals spans more than two decades. He also served as a Biotechnology Analyst at Donaldson, Lufkin & ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

Co-Founder and Director
Vice Chairman and Managing Director
Director
1991-N/A
Former Director
1994-Present
Co-Founder, Chairman and Member of Audit Committee
2000-2011
Former Co-Founder, Chairman, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee
2001-2006
Former Director
2003-2006
Former Director
2003-Present
Director, Chairman of Nominating & Governance Committee and Member of Compensation Committee
2008-Present
Chairman, Member of Finance & Audit Committee and Member of Science & Technology Committee
2009-Present
Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee

Education*

PhD
New York University
MBA
New York University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$74,000
Total Calculated Compensation$554,855
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $3.65 USD +0.055

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.